US 9562230
Transferrin/transferrin receptor-mediated siRNA delivery
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 9562230 (Transferrin/transferrin receptor-mediated siRNA delivery) held by Arrowhead Pharmaceuticals, Inc. expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/64, A61K47/644